Relationship between objectively-measured physical activity levels† and health status
Variable | Pearson correlation coefficient | |||
---|---|---|---|---|
Physical activity level | Per cent predicted MaxVo2 | Per cent predicted Vo2 at VAT | Per cent predicted MaxWork | |
R | R | r | r | |
*p<0.05. | ||||
†Reported as number of minutes per day spent in moderate or vigorous physical activity, after logarithmic transformation. | ||||
CHAT, Congenital Heart Adolescent and Teenage Questionnaire; CHQ, Child Health Questionnaire; MaxVo2, maximum oxygen consumption at peak exercise; MaxWork, maximum work rate; Vo2 at VAT, oxygen consumption at anaerobic threshold. | ||||
CHQ Parent Report | ||||
Global health | 0.08 | 0.39* | 0.45* | 0.33* |
Physical functioning limitations | 0.04 | 0.21* | 0.24* | 0.29* |
Impact of emotional or | –0.04 | –0.08 | –0.11 | 0.02 |
behavioural problems - school or work | ||||
Impact of physical limitations - school or work | 0.11 | 0.21* | 0.24* | 0.29* |
Bodily pain | 0.14 | 0.12 | 0.02 | 0.11 |
General behaviour problems | –0.03 | –0.19* | –0.15 | –0.09 |
Mental health | 0.05 | 0.03 | 0.14 | 0.05 |
Self esteem | 0.08 | 0.17 | 0.28* | 0.07 |
General health perceptions | 0.23* | 0.25* | 0.15 | 0.36* |
Impact on parent of child’s health - parent worries/concerns | –0.03 | 0.14 | 0.22* | 0.17 |
Impact on parent of child’s health - time restrictions | –0.05 | 0.02 | 0.05 | 0.15 |
Family activities | 0.13 | –0.07 | –0.03 | 0.03 |
Family cohesion | 0.14 | 0.11 | 0.26* | 0.02 |
Overall physical functioning summary score | 0.14 | 0.29* | 0.26* | 0.38* |
Overall psychosocial functioning summary score | –0.04 | –0.05 | 0.05 | 0.01 |
CHAT Questionnaire | ||||
General health | 0.04 | –0.19 | –0.34* | –0.11 |
Social life | –0.01 | 0.03 | –0.19 | –0.08 |
Seriousness of condition | –0.01 | 0.01 | 0.01 | –0.03 |
Activity limitations | –0.22 | –0.32* | –0.34* | –0.32* |
Emotional concerns | 0.02 | –0.04 | 0.01 | –0.18 |
Friendship concerns | –0.21 | –0.17 | –0.12 | –0.25* |
Career concerns | –0.04 | –0.12 | –0.16 | –0.22* |
Symptom concerns | –0.02 | –0.25* | –0.22 | –0.21* |